journal article·2026-01Open access

Multi-omics qualification of an organ-on-a-chip model of osteolytic bone metastasis

Natalia Munoz Castro, Joanne Nolan, Eleni Maniati, Ayushi Agrawal, Valentine Gauthier, Oliver M.T. Pearce, Stefaan W. Verbruggen, Martin M. Knight

Acta Biomaterialia· Volume 209

Abstract

Bone is a primary site for metastasis in breast cancer, with up to 70 % of patients with metastatic breast cancer developing osteolytic bone lesions, wherein cancer cells drive osteoclast resorption of bone. However, progress in developing therapies is limited by the absence of predictive in vitro models. This study developed a unique organ-on-a-chip model to simulate osteolytic bone metastasis and utilised a multi-omics approach for characterisation/qualification and validation against in vivo data. Using the Emulate S1 platform, we co-cultured murine osteocytes and osteoclasts to recreate the bone microenvironment, alongside breast cancer cells in a separate channel separated by a porous membrane. Using RNA sequencing, cytokine profiling, and fluorescence staining, we demonstrated the importance of the complete tri-culture model in replicating key aspects of in vivo biology, and uncovered critical pathways involved in metastasis. A synergistic effect was observed in the tri-culture organ-chip model, leading to increased cancer cell migration and the upregulation of pro-metastatic and pro-inflammatory pathways that promote bone degradation and cancer progression. This study validates an organ-chip model of osteolytic breast cancer bone metastasis as a scalable alternative to traditional animal models. Furthermore, we show how multi-omics and bioinformatics techniques may be used for qualification and validation of organ-chip models; for unpicking the relative contribution of the different cell types; and to identify signalling pathways and therapeutic targets. STATEMENT OF SIGNIFICANCE: In this study, we develop a 3D organ-on-a-chip tri-culture model of the osteolytic metastatic niche, in which we verify expected bone and breast cancer cell behaviours. Importantly, we successfully validate our organ-chip against a dataset from the gold standard in vivo preclinical model of osteolytic breast metastases, using transcriptomics and proteomics to confirm strong alignment of gene expression profiles with in vivo mouse expression. Additionally, our multi-omics analysis sheds new light on both expected and novel molecular pathways for therapeutic targeting, demonstrating the utility of the organ-chip as a potential replacement for preclinical mouse models of breast cancer metastases in bone. Therefore, this study represents a key marker in the field of organ-chip research, demonstrating the importance of biomaterials technologies for preclinical science. Most importantly, our work demonstrates for biotech and pharma companies that qualified organ-chip devices can play a role as intermediate medium-throughput technologies for screening lead drug candidates.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer Cells and Metastasis · 3D Printing in Biomedical Research · Biomarkers in Disease Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Bone metastasis of breast cancer10.1007/978-3-030-20301-6_7 ↗
2. Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval10.1136/bmjopen-2015-007702 ↗
3. Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark10.1186/1471-2407-11-29 ↗
4. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study10.1186/s12885-020-07593-8 ↗
5. Predicting diagnosis and survival of bone metastasis in breast cancer using machine learning10.1038/s41598-023-45438-z ↗
6. Prognostic factors in patients with metastatic breast cancer with bone-only metastases10.1634/theoncologist.2018-0085 ↗
7. Diagnosis and treatment of bone metastases in breast cancer: radiotherapy, local approach and systemic therapy in a guide for clinicians10.3390/cancers12092390 ↗
8. Role of mitochondrial alterations in human cancer progression and cancer immunity10.1186/s12929-023-00956-w ↗
9. Bisphosphonates and breast cancer–from cautious palliation to saving lives10.1016/j.bone.2020.115570 ↗
10. Bisphosphonates in common pediatric and adult bone sarcomas10.1016/j.bone.2020.115523 ↗
11. Bisphosphonates: from the laboratory to the clinic and back again10.1016/S8756-3282(99)00116-7 ↗
12. TGF-β-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases10.1158/0008-5472.CAN-10-2651 ↗
13. Tgfβ inhibition stimulates collagen maturation to enhance bone repair and fracture resistance in a murine myeloma model10.1002/jbmr.3859 ↗
14. Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-β type I receptor kinase in vivo10.1158/1078-0432.CCR-06-0162 ↗
15. Genetic mouse models for bone studies—Strengths and limitations10.1016/j.bone.2011.08.021 ↗
16. Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail10.1186/s12967-018-1678-1 ↗
17. The flaws and human harms of animal experimentation10.1017/S0963180115000079 ↗
18. Is it time for reviewer 3 to request human organ chip experiments instead of animal validation studies?10.1002/advs.202002030 ↗
19. Osteocyte-like cells differentiated from primary osteoblasts in an artificial Human bone tissue model
20. A detailed methodology for the long-term in vitro culture and analysis of three-dimensional, self-structuring bone models generated from cell lines or primary osteoblastic cell populations [version 2; peer review: 1 approved, 3 approved with reservations]
21. Mature primary human osteocytes in mini organotypic cultures secrete FGF23 and PTH1-34-regulated sclerostin10.3389/fendo.2023.1167734 ↗
22. Molecular mechanisms and clinical management of cancer bone metastasis10.1038/s41413-020-00105-1 ↗
23. Breast cancer metastasis to the bone: mechanisms of bone loss10.1186/bcr2781 ↗
24. Mechanisms, diagnosis and treatment of bone metastases10.3390/cells10112944 ↗
25. Osteocyte signaling in bone10.1007/s11914-012-0105-4 ↗
26. Quantifying the osteocyte network in the human skeleton10.1016/j.bone.2015.02.016 ↗
27. Microfluidic platform for studying osteocyte mechanoregulation of breast cancer bone metastasis10.1093/intbio/zyz008 ↗
28. Mechanically stimulated osteocytes reduce the bone-metastatic potential of breast cancer cells in vitro by signaling through endothelial cells10.1002/jcb.28034 ↗
29. New roles of osteocytes in proliferation, migration and invasion of breast and prostate cancer cells
30. Mechanically stimulated osteocytes promote the proliferation and migration of breast cancer cells via a potential CXCL1/2 mechanism10.1016/j.bbrc.2020.12.016 ↗
31. A biomimetic 3D model of hypoxia-driven cancer progression10.1038/s41598-019-48701-4 ↗
32. Investigating the mechanobiology of cancer cell–ECM interaction through collagen-based 3D scaffolds10.1007/s12195-017-0483-x ↗
33. Mechanical stimulation modulates osteocyte regulation of cancer cell phenotype10.3390/cancers13122906 ↗
34. Role of osteocytes in cancer progression in the bone and the associated skeletal disease10.1007/s11914-021-00679-7 ↗
35. The role of osteocytes in pre-metastatic niche formation10.1007/s11914-023-00857-9 ↗
36. The mechanosensory role of osteocytes and implications for bone health and disease states10.3389/fcell.2021.770143 ↗
37. Ortiz · 2012 · 225
38. Organ-on-a-chip: an emerging research platform
39. Alternatives of animal models for biomedical research: a comprehensive review of modern approaches10.1007/s12015-024-10701-x ↗
40. 3D and organoid culture in research: physiology, hereditary genetic diseases and cancer10.1186/s13578-022-00775-w ↗
41. Organs-on-a-chip: a fast track for engineered human tissues in drug development10.1016/j.stem.2018.02.011 ↗
42. Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing
43. Techniques for studying mechanobiology
44. High-resolution RNA sequencing from PFA-fixed microscopy sections
45. Streamlined full-length total RNA sequencing of paraformaldehyde-fixed brain tissues10.3390/ijms25126504 ↗
46. Fixed single-cell RNA sequencing for understanding virus infection and host response
47. Changes in cytokines of the bone microenvironment during breast cancer metastasis10.1155/2012/160265 ↗
48. Role of the osteocyte in bone metastasis–The importance of networking10.1016/j.jbo.2024.100526 ↗
49. Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone10.1038/sj.bjc.6602417 ↗
50. IL-6 exhibits both cis-and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis10.1074/jbc.RA119.008074 ↗
51. Osteocytes and primary cilia10.1007/s11914-023-00819-1 ↗
52. Triggering a switch from basal-to luminal-like breast cancer subtype by the small-molecule diptoindonesin G via induction of GABARAPL110.1038/s41419-020-02878-z ↗
53. A mechanobiological model of bone metastasis reveals that mechanical stimulation inhibits the pro-osteolytic effects of breast cancer cells10.1016/j.celrep.2024.114043 ↗
54. Murine models of breast cancer bone metastasis10.1038/bonekey.2016.31 ↗
55. CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes/macrophages10.7150/thno.29617 ↗
56. Relatively rare populations of invasive cells drive progression of heterogeneous tumors10.1007/s12195-023-00792-w ↗
57. The osteocyte: an endocrine cell… and more10.1210/er.2012-1026 ↗
58. Systematic optimization and evaluation of culture conditions for the construction of circulating tumor cell clusters using breast cancer cell lines10.1186/s12885-024-12214-9 ↗
59. Strain amplification in bone mechanobiology: a computational investigation of the in vivo mechanics of osteocytes10.1098/rsif.2012.0286 ↗
60. A novel primary cilium-mediated mechanism through which osteocytes regulate metastatic behavior of both breast and prostate cancer cells10.1002/advs.202305842 ↗
61. Myosin regulates intracellular force and guides collective cancer cell migration via the FAK-Rho/ROCK feedback loop10.1016/j.gendis.2023.02.037 ↗
62. Nuclear mechanics and cancer cell migration
63. Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population10.1186/s13104-018-3477-4 ↗
64. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors10.1186/s10020-021-00274-7 ↗
65. MAP3K1: genomic alterations in cancer and function in promoting cell survival or apoptosis10.1177/1947601913513950 ↗
66. Rock2 promotes the invasion and metastasis of hepatocellular carcinoma by modifying MMP2 ubiquitination and degradation10.1016/j.bbrc.2014.09.061 ↗
67. Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer10.1371/journal.pone.0183871 ↗
68. ITGB1BP1, a novel transcriptional target of CD44-downstream signaling promoting cancer cell invasion
69. Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets10.1186/s12964-023-01338-3 ↗
70. SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis10.1007/s00432-020-03247-1 ↗
71. BRCA1 and breast cancer: molecular mechanisms and therapeutic strategies10.3389/fcell.2022.813457 ↗
72. MYC and breast cancer10.1177/1947601910378691 ↗
73. IGF-1R mediates crosstalk between nasopharyngeal carcinoma cells and osteoclasts and promotes tumor bone metastasis10.1186/s13046-024-02970-8 ↗
74. Bad to the bone: the role of the insulin-like growth factor axis in osseous metastasis10.1158/1078-0432.CCR-18-2697 ↗
75. Interleukin-6 in bone metastasis and cancer progression10.1016/j.ejca.2010.02.026 ↗
76. Classical and paradoxical effects of TNF-α on bone homeostasis10.3389/fimmu.2014.00048 ↗
77. Mechanical–chemical coupled modeling of bone regeneration within a biodegradable polymer scaffold loaded with VEGF10.1007/s10237-020-01339-y ↗
78. The M-CSF receptor in osteoclasts and beyond10.1038/s12276-020-0484-z ↗
79. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families10.1210/edrv.20.3.0367 ↗
80. Osteoclast formation in mouse co-cultures
81. Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy10.1136/jitc-2022-004669 ↗
82. The emerging role of ISWI chromatin remodeling complexes in cancer10.1186/s13046-021-02151-x ↗
83. Targeting chromatin-remodeling factors in cancer cells: promising molecules in cancer therapy
84. Multilevel view on chromatin architecture alterations in cancer10.3389/fgene.2022.1059617 ↗
85. Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes10.1038/s41467-024-47793-5 ↗
86. Rac and rho GTPases in cancer cell motility control10.1186/1478-811X-8-23 ↗
87. Targeting Rho GTPase signaling networks in cancer10.3389/fcell.2020.00222 ↗
88. CXCL10 promotes osteolytic bone metastasis by enhancing cancer outgrowth and osteoclastogenesis10.1158/0008-5472.CAN-12-0481 ↗
89. Osteoclast signal transduction during bone metastasis formation10.3389/fcell.2020.00507 ↗
90. Mitochondria in tumor immune surveillance and tumor therapies targeting mitochondria10.1007/s13402-024-01000-1 ↗
91. Intersecting paths: unraveling the complex journey of cancer to bone metastasis10.3390/biomedicines12051075 ↗
92. Deciphering molecular mechanisms of metastasis: novel insights into targets and therapeutics10.1007/s13402-021-00611-2 ↗
93. Osteoblasts and osteoclasts: an important switch of tumour cell dormancy during bone metastasis10.1186/s13046-022-02520-0 ↗
94. Perturbing the dynamics and organization of cell membrane components: a new paradigm for cancer-targeted therapies10.3390/ijms19123871 ↗
95. Cell3: a new vision for study of the endomembrane system in mammalian cells10.1042/BSR20210850C ↗
96. Disrupted osteocyte connectivity and pericellular fluid flow in bone with aging and defective TGF-β signaling10.1073/pnas.2023999118 ↗
97. Mechanical regulation of breast cancer migration and apoptosis via direct and indirect osteocyte signaling10.1002/jcb.26745 ↗
98. Osteocyte apoptosis regulates osteoclast precursor adhesion via osteocytic IL-6 secretion and endothelial ICAM-1 expression10.1016/j.bone.2011.09.052 ↗
99. IL-6 alters osteocyte signaling toward osteoblasts but not osteoclasts10.1177/0022034514522485 ↗
100. The dual role of IL-6-type cytokines on bone remodeling and bone tumors10.1016/j.cytogfr.2008.11.004 ↗